A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens.
Saved in:
| Title: | A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. |
|---|---|
| Authors: | Kratochvil S; Imperial College London, Medicine, London, UK., McKay PF; Imperial College London, Medicine, London, UK., Kopycinski JT; Nuffield, University of Oxford, Medicine, Oxford, UK., Bishop C; Flow Cytometry Core Facility, Biomedical Research Centre, Guy's Hospital, London, UK., Hayes PJ; Human Immunology Laboratory, IAVI, London, UK., Muir L; Imperial College London, Medicine, London, UK., Pinder CL; Imperial College London, Medicine, London, UK., Cizmeci D; Imperial College London, Medicine, London, UK., King D; Human Immunology Laboratory, IAVI, London, UK., Aldon Y; Imperial College London, Medicine, London, UK., Wines BD; Burnet Institute, Melbourne, VIC, Australia., Hogarth PM; Burnet Institute, Melbourne, VIC, Australia., Chung AW; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia., Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre, Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC, Australia., Held K; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany., Geldmacher C; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany., Dally L; Emmes Corporation, Rockville, MD, USA., Santos NS; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK., Cole T; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK., Gilmour J; Human Immunology Laboratory, IAVI, London, UK., Fidler S; Imperial College London, Medicine, London, UK., Shattock RJ; Imperial College London, Medicine, London, UK. |
| Source: | Frontiers in immunology [Front Immunol] 2017 May 24; Vol. 8, pp. 595. Date of Electronic Publication: 2017 May 24 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28596770 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kratochvil+S%22">Kratochvil S</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22McKay+PF%22">McKay PF</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Kopycinski+JT%22">Kopycinski JT</searchLink>; Nuffield, University of Oxford, Medicine, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Bishop+C%22">Bishop C</searchLink>; Flow Cytometry Core Facility, Biomedical Research Centre, Guy's Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Hayes+PJ%22">Hayes PJ</searchLink>; Human Immunology Laboratory, IAVI, London, UK.<br /><searchLink fieldCode="AU" term="%22Muir+L%22">Muir L</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Pinder+CL%22">Pinder CL</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Cizmeci+D%22">Cizmeci D</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22King+D%22">King D</searchLink>; Human Immunology Laboratory, IAVI, London, UK.<br /><searchLink fieldCode="AU" term="%22Aldon+Y%22">Aldon Y</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Wines+BD%22">Wines BD</searchLink>; Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Hogarth+PM%22">Hogarth PM</searchLink>; Burnet Institute, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Chung+AW%22">Chung AW</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Kent+SJ%22">Kent SJ</searchLink>; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne, VIC, Australia.; Melbourne Sexual Health Centre, Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University, Melbourne, VIC, Australia.<br /><searchLink fieldCode="AU" term="%22Held+K%22">Held K</searchLink>; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Geldmacher+C%22">Geldmacher C</searchLink>; Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU), Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Dally+L%22">Dally L</searchLink>; Emmes Corporation, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Santos+NS%22">Santos NS</searchLink>; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Cole+T%22">Cole T</searchLink>; NIHR/Wellcome Trust Imperial Clinical Research Facility Hammersmith Hospital, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Gilmour+J%22">Gilmour J</searchLink>; Human Immunology Laboratory, IAVI, London, UK.<br /><searchLink fieldCode="AU" term="%22Fidler+S%22">Fidler S</searchLink>; Imperial College London, Medicine, London, UK.<br /><searchLink fieldCode="AU" term="%22Shattock+RJ%22">Shattock RJ</searchLink>; Imperial College London, Medicine, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2017 May 24; Vol. 8, pp. 595. <i>Date of Electronic Publication: </i>2017 May 24 (<i>Print Publication: </i>2017). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1664-3224 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28596770 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2017.00595 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 595 Titles: – TitleFull: A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kratochvil S – PersonEntity: Name: NameFull: McKay PF – PersonEntity: Name: NameFull: Kopycinski JT – PersonEntity: Name: NameFull: Bishop C – PersonEntity: Name: NameFull: Hayes PJ – PersonEntity: Name: NameFull: Muir L – PersonEntity: Name: NameFull: Pinder CL – PersonEntity: Name: NameFull: Cizmeci D – PersonEntity: Name: NameFull: King D – PersonEntity: Name: NameFull: Aldon Y – PersonEntity: Name: NameFull: Wines BD – PersonEntity: Name: NameFull: Hogarth PM – PersonEntity: Name: NameFull: Chung AW – PersonEntity: Name: NameFull: Kent SJ – PersonEntity: Name: NameFull: Held K – PersonEntity: Name: NameFull: Geldmacher C – PersonEntity: Name: NameFull: Dally L – PersonEntity: Name: NameFull: Santos NS – PersonEntity: Name: NameFull: Cole T – PersonEntity: Name: NameFull: Gilmour J – PersonEntity: Name: NameFull: Fidler S – PersonEntity: Name: NameFull: Shattock RJ IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 05 Text: 2017 May 24 Type: published Y: 2017 Identifiers: – Type: issn-print Value: 1664-3224 Numbering: – Type: volume Value: 8 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |
